11th International Congress

Transcription

1 11th International Congress From October 8 to 11, 2013»»» Bellevue Center of Congress Biarritz - France /// Plenary sessions /// Debates /// Workshops /// Posters Addiction Hepatitis AIDS N Formateur

2 pm THS 11 Opening Speech In the presence of : Alain ROUSSET (Président de la Région Aquitaine), Georges LABAZEE (Président du Conseil Général des Pyrénées- Atlantiques), Didier BOROTRA (Maire de Biarritz), Albert HERSZKOWICZ (Représentant de la Direction Générale de la Santé) and Martine VALADIE-JEANNEL (Agence Régionale de Santé Aquitaine) pm simultaneously Conference/debate : : : Medical Marijuana and legalization [ translated Moderation : Amine BENYAMINA (Villejuif) Medical marijuana : myths et realities : : : Herbert KLEBER (New York) Medical marijuana and legalization in Colorado : notes from the fi eld : : : Robert BOOTH (Denver) As a tribute to : «Science sans conscience n est que ruine de l âme.» François Rabelais «Plaisante justice qu une rivière ou qu une montagne borne! Vérité en deçà des Pyrénées, erreur au-delà.» Blaise Pascal «Il est des circonstances où se taire est mentir.» Miguel De Unamuno (Discours de Salamanque) Under the High Patronage of Marisol TOURAINE Ministre des Affaires Sociales et de la Santé Danièle JOURDAIN MENNINGER Présidente de la MILDT Alain ROUSSET Président de la Région Aquitaine Georges LABAZEE Président du Conseil Général des Pyrénées-Atlantiques Michel LAFORCADE Directeur de l Agence Régionale de Santé Aquitaine Didier BOROTRA Maire de Biarritz Under the Honorary Presidency of Françoise BARRE-SINOUSSI (Paris) Under the Presidency of Charles O BRIEN (Philadelphie) Christian TREPO (Lyon) Under the Direction of Jean-Pierre DAULOUEDE (Bayonne) Secrétaire Général du Congrès, Directeur du colloque Arkaitz AGUERRETXE COLINA (Bayonne) Secrétaire Général Adjoint, Directeur Adjoint du colloque Marc AURIACOMBE (Bordeaux) Président du Comité scientifi que du colloque In collaboration with Jean-Jacques DEGLON (Genève) Président de la SETHS With the support of :

3 am simultaneously Plenary Session : : : Opiate addiction treatments : efficacy, safety and availability [ translated Co-chair : Icro MAREMMANI (Pisa) and Jean-Jacques DEGLON (Geneva) Moderation : Marc AURIACOMBE (Bordeaux) pm Rhune 1 The opioid agonist maintenance treatment : state of the art : : : Marta TORRENS (Barcelona) Starting treatments with agonist replacement therapies (START Study) : a randomized trial comparing methadone and buprenorphine on liver health and other outcomes : : : Andrew SAXON (Seattle) Methadone induction in primary care for opioid dependence : a pragmatic trial (ANRS Methaville) : : : Patrizia CARRIERI (Marseille) Acceptability and safety of the buprenorphine/naloxone combination in heroin addicts (RIME study) : : : Didier TOUZEAU (Paris), discutant : Marc AURIACOMBE (Bordeaux) Expanding substance abuse treatment options for HIV prevention and care : : : David METZGER (Bethesda) Diversion, misuse and traffi cking of methadone and buprenorphine (RADARS System) : : : Richard DART (Denver) Opioid antagonists treatments : : : Charles O BRIEN (Philadelphia) pm Lunch *** Poster session simultaneously Plenary Session : : : Recent development about cannabis [ translated Chair : Amine BENYAMINA (Villejuif) C3,17-NMPDs : a new therapeutic class to treat marijuana abuse : : : Pier Vincenzo PIAZZA (Bordeaux) New clinical data : : : Alain DERVAUX (Paris) Addictive behaviour in adolescents : : : Olivier PHAN (Paris) Marijuana, where do we stand? : : : Amine BENYAMINA (Villejuif) Workshop 1 / Pharmacists and addictions /// Moderation : Nicolas BONNET (Paris) From 94 to 93 : 10 years evolution of needle exchange programs in pharmacies of the Ile-de-France area /// Lionel SAYAG (Montreuil) A needle exchange program in pharmacies : experience of the Logos center (Nîmes) /// Michel LEMONNIER (Nîmes) Early screening-brief intervention in pharmacies /// Bernard PENICAUD (Niort) Stakes of the training of pharmacists students to early screening/brief intervention /// Judith ANDRE (Amiens) Workshop 2 / Addictions, HIV and HCV in prisons Moderation : Fadi MEROUEH (Villeneuve-lès-Maguelone) and Saadia YAKOUB (Paris) Harm reduction in prisons : Comprehensive Package /// Fabienne HARIGA (Vienna) Opiate maintenance treatments and harm reduction in prisons : an overview /// Fadi MEROUEH (Montpellier) Needle exchange program : the Swizterland example /// Anne FRANCOIS (Geneva) Prevalence of viral infections in drug users in Algeria /// Mohamed Salah LAIDLI (Alger) «The therapeutic education of patients with HCV» /// Henri MARTEAU (Villeneuve-lès-Maguelone) Rhune Vagues Workshop 3 / Designer drugs / Moderation : Marie DEBRUS (Paris) New synthetic drugs: users, risks and harm reduction /// Grégory PFAU (Paris) Harm reduction to the test of new synthetic drugs /// Vincent BENSO (Paris) pm Break ))) Partnerships : Association Nationale des Généralistes pour la Recherche et l Étude sur les Hépatopathies Chroniques graphisme : [email protected]

4 pm simultaneously translated [ Plenary Session : : : Addictions, hepatitis, AIDS from northern to southern countries Co-chair : Gilles RAGUIN (Paris) and Don DES JARLAIS (New York) UDSEN/RDR project in Senegal : : : Maryvonne MAYNARD (Dakar) Coinfection HIV/HVC North/South : : : Karine LACOMBE (Paris) Krokodile Injectors in Donetsk, Nikolayev and Odessa, Ukraine : : : Robert BOOTH (Denver) Project in Vietnam : : : Nguyen Quynh MAI (Hanoi) Hepatitis, migrants and harm reduction : experience in Bordeaux : : : Olivier DONNEVIDE (Bordeaux) Rhune 1 Workshop 1 / Craving, use, relapse and DSM 5. Is craving a diagnosis and a therapeutic target? Partnership with Bordeaux II University Co-chair : Charles O BRIEN (Philadelphia) and Marc AURIACOMBE (Bordeaux) Discutant : Nicolas AUTHIER (Clermont-Ferrand) Is DSM 5 dangerous for the population? Some truths /// Marc AURIACOMBE (Bordeaux) Can we study subjective phenomenoms in an objective way? How to define craving? /// Joël SWENDSEN (Bordeaux) Are there biological markers or individual vulnerability associated to craving and relapse? /// Mélina FATSEAS (Bordeaux) Is really craving the cause of use in addicts? Can environment contribute to craving? /// Fuschia SERRE (Bordeaux) Can craving be a therapeutic target? /// Arkaitz AGUERRETXE COLINA (Bayonne) Workshop 2 / Tobacco : what s new? / Moderation : Nicolas BONNET (Paris) Tobacco addiction and harm reduction /// Jean-Pierre COUTERON (Paris) Subtance abuse expert and e-cigarette /// Anne BORGNE (Paris) Specifics of the care of pregnant and post partum women /// Cathy MEIER (Pau) Vagues1 Workshop 3 / Addictions and work / Moderation : Pierre POLOMENI (Paris) Rhune Using psychoactive substances and working : what about the secret? /// Pierre POLOMENI (Paris) «FIDES mission» : prevention and support of Paris hospital s staff /// Isabelle CHAVIGNAUD (Paris) Preventing addictions at work : a collective step /// Carole GAYET (Paris) Local initiatives in substance disorders prevention at work : between tensions and opportunities /// Anne-Cécile RAHIS (Bordeaux) THS 2011

5 am am simultaneously Plenary Session : : : Alcohol : innovation or following? [ translated Co-chair : Amine BENYAMINA (Villejuif) and Charles O BRIEN (Philadelphia) What about the abstinence dogma? : : : Henri-Jean AUBIN (Villejuif) Opioid modulation in abstinence maintenance : : : Charles O Brien (Philadelphia) Baclofene : the age of reason : : : Michel REYNAUD (Villejuif) Nalméfène : a new therapeutic strategy in reducing alcohol use : : : Karl MANN (Mannhein) simultaneously [ translated Plenary Session : : : AIDS and hepatitis Co-chair : Jacques NORMAND (Bethesda) and Jean-François DELFRAISSY (Paris), moderation : Philippe CHOSSEGROS (Lyon) pm Lunch *** Poster session pm simultaneously Plenary Session : : : Medical heroin, morphine and buprenorphine [ translated Co-chair : Miguel CASAS (Barcelona) and Ambros UCHTENHAGEN (Zurich) Adding contingency management to heroin asssisted treatment in order to reduce cocaine consumption in polydrug using treatment refractory heroin dependent patients : : : Wim VAN DEN BRINK (Amsterdam) Oral morphin treatments : : : Gabriele FISCHER (Vienna) About a new galenic form in oral diacetylmorphin treatments : : : Miguel CASAS (Barcelona) Feasibility, effi cacy and acceptability of injected buprenorphine as treatment for opiate users who persist in injecting illicit heroin through opiate maintenance treatment : : : Rob VANDERWAAL (London) Assessment and outcome of psychiatric comorbidity in heroin assisted treatment : : : Ambros UCHTENHAGEN (Zurich) Rhune 1 Workshop 1 /Addictions, hepatitis, AIDS and precariousness /// Symposium organized and sponsorised by Médecins du Monde Moderation : Jean-François CORTY (Paris), Grand témoin : Jean-Pierre DAULOUEDE (Bayonne) Social acceptability of innovative measures aiming at precarious public : example of drug consumption rooms in France /// Marie JAUFRRET ROUSTIDE (Paris) Edges : innovations creators /// Olivier MAGUET (Paris) Program on education on the risks of injecting : testimony of a user /// Jean-Guillaume (Paris) Vagues am Break ))) New perpectives in Hepatitis treatment : : : Pascal MELIN (Saint Dizier) Addiction clinics, prisons : the end of HCV in 2020? : : : Victor DE LEDINGHEN (Bordeaux) A role for chronic infl ammation in HIV? What about drug users? : : : Laurence WEISS (Paris) Is there a good way to consider viral epidemics in drug users? : : : Philippe CHOSSEGROS (Lyon) Workshop 2 / The French Society of Tobacco Addiction (Société Française de Tabacologie - SFT) Moderation : Didier TOUZEAU (Paris) Binge eating, bulimia and tobacco /// Alice DECHENAU and Alice DECHENAU and Didier TOUZEAU (Paris) Care of tobacco addiction before bariatric surgery in Nancy universitary hospital /// Nathalie WIRTH (Nancy) E-Cigarette /// Gérard MATHERN (Saint Chamond) Workshop 3 / Rapid tests HIV-HCV in drug users (ANGREHC) Moderation : Xavier AKNINE (Bondy) The TROD-VELIBE study in addiction clinic and general practitioners /// Cedrick MOREAU (Paris) Follow-up of seroconversions to HCV in GP s offi ces : HEPCORT Study /// Xavier AKNINE (Paris) Blotting paper, an alternative to veinous sample : facilitating access to HIV, HCV and HBV screening /// Jacques DUCOS and Fadi MEROUEH (Montpellier) Care of HCV in addiction clinics : example of EGO clinic in Paris and Arc En Ciel in Montpellier /// Jean-François BIGNON and Claire NOBLET (Paris) and Fadila DEHAS (Montpellier) pm Break ))) pm simultaneously [ translated Symposium /// Organised and sponsorised by Reckitt Benckiser Pharmaceuticals Chair : Jean-Louis SAN MARCO (Marseille) Do we need to update the opiate maintenance treatments guidelines in France? Focus on practices 9 years after the 2004 consensus conference. === Nicolas AUTHIER (Clermont-Ferrand) Misuse and diversion of OST in France, where we stand in 2013? === Maurice DEMATTEIS (Grenoble) Addiction to analgesic opioïds ; the US experience, RADARS System === Richard DART (Denver) pm Congress Dinner ###

6 am am simultaneously [ translated Plenary Session : : : Innovative devices in harm reduction linked to substance use and addictions Co-chair : Mary Jeanne KREEK (New York) and Christian TREPO (Lyon) Moderation : Patrizia CARRIERI (Marseille) Discovery in : Identifi cation of drug users as HIV-1/AIDS second risk group and methadone treatment as prevention : : : Mary Jeanne KREEK (New York) Systematic review of the effectiveness of needle/syringe programs and opiate substitution therapy in low and middle income : : : Don DES JARLAIS (New York) Buprenorphine as HIV prevention in NSPs-needle syringe programs : : : Jason FARRELL (New York) Confi rmation that French harm reduction policy is still effi cient against HIV and HCV : biological and behavioral data : : : Cécile DENIS (Bordeaux/Philadelphia) Innovation and community approach with drug users : a «crak kit» to reduce risk of HCV transmission : : : Marie JAUFFRET ROUSTIDE (Paris) Supervised injection facilities : a harm reduction model. The Catalan experience : : : Joan COLOM (Barcelona) am Break ))) simultaneously [ translated Plenary Session : : : Substance use, HIV, HCV and evidence based drug policies Co-chair : Brandon MARSHALL (Vancouver) and Marc REISINGER (Brussels) Moderation : Pierre CHAPARD (Paris) Developments and limits of the French harm reduction policy model : : : Marie JAUFFRET ROUSTIDE (Paris) The role of the scientifi c community in the shaping of evidence-based drug policy : Vancouver s supervised injection site as an illuminating example : : : Brandon MARSHALL (Vancouver) Challenging assumptions about drugs : : : Carl HART (New York) Treating treatment systems : : : Marc REISINGER (Brussels) pm Lunch *** Poster session pm simultaneously Plenary Session : : : Misuse and addiction to pain killers [ translated Chair : Nicolas AUTHIER (Clermont-Ferrand), moderation : Maurice DEMATTEIS (Grenoble) Epidemiologic data : : : Nicolas AUTHIER (Clermont-Ferrand) Study on withdrawal strategies with level 2 analgesics (tramadol, codein, opium powder) : : : Anne ROUSSIN (Toulouse) Addiction specialist point of view : : : Philippe LACK (Lyon) Is there a genetic predisposition to develop analgesic addiction? : : : Michel MALLARET (Grenoble) Rhune 1 Vagues 1+2 Workshop 1 / Survival / Moderation : Jean-Jacques DEGLON (Geneva) and Georges-Henri MELENOTTE (Strasbourg) Discutant : Jacques JUNGMAN (Paris) Addiction : a strategy for survival? /// Laurent GOURARIER (Paris) Workshop 2 / Behavioral addictions / Chair : Jean-Luc VENISSE (Nantes) Sexual addiction : clinical and therapeutic approach /// Marthylle LAGADEC (Villejuif) Anabolic steroids : from high level sport to fi tness centers /// Victor AGULLO (Valence) Gambling Disorder and DSM 5 : what s new? /// Cécile DENIS (Bordeaux/Philadelphia) Workshop 3 / Medical marijuana / Moderation : Laurent APPEL (Paris) Medical marijuana in substance use disorders /// Fabienne LOPEZ (Paris) Testimony about marijuana use in maintenance of opiate abstinence /// Jérôme TETAZ (Chambéry) Cocaine, crack, cristal-meth and marijuana /// Laurent APPEL (Paris) pm Closing Session